Stoichiometry of the antiviral protein APOBEC3G in HIV-1 virions. Export

@article{citeulike:3702742, abstract = {A host cytidine deaminase, APOBEC3G (A3G), inhibits replication of human immunodeficiency virus type 1 (HIV-1) by incorporating into virions in the absence of the virally encoded Vif protein (Deltavif virions), at least in part by causing G-to-A hypermutation. To gain insight into the antiretroviral function of A3G, we determined the quantities of A3G molecules that are incorporated in Deltavif virions. We combined three experimental approaches-reversed-phase high-pressure liquid chromatography (HPLC), scintillation proximity assay (SPA), and quantitative immunoblotting-to determine the molar ratio of A3G to HIV-1 capsid protein in Deltavif virions. Our studies revealed that the amount of the A3G incorporated into Deltavif virions was proportional to the level of its expression in the viral producing cells, and the ratio of the A3G to Gag in the Deltavif virions produced from activated human peripheral blood mononuclear cells (PBMC) was approximately 1:439. Based on previous estimates of the stoichiometry of HIV-1 Gag in virions (1400-5000), we conclude that approximately 7 (+/-4) molecules of A3G are incorporated into Deltavif virions produced from human PBMCs. These results indicate that virion incorporation of only a few molecules of A3G is sufficient to inhibit HIV-1 replication.}, author = {Xu, H. and Chertova, E. and Chen, J. and Ott, D. E. and Roser, J. D. and Hu, W. S. and Pathak, V. K.}, citeulike-article-id = {3702742}, citeulike-linkout-0 = {http://dx.doi.org/10.1016/j.virol.2006.10.036}, citeulike-linkout-1 = {http://view.ncbi.nlm.nih.gov/pubmed/17126871}, citeulike-linkout-2 = {http://www.hubmed.org/display.cgi?uids=17126871}, day = {10}, doi = {10.1016/j.virol.2006.10.036}, issn = {0042-6822}, journal = {Virology}, keywords = {apobec, packaging}, month = {April}, number = {2}, pages = {247--256}, posted-at = {2008-11-26 10:37:45}, priority = {2}, title = {Stoichiometry of the antiviral protein APOBEC3G in HIV-1 virions.}, url = {http://dx.doi.org/10.1016/j.virol.2006.10.036}, volume = {360}, year = {2007} }

TY - JOUR ID - citeulike:3702742 L3 - citeulike-article-id:3702742 N2 - A host cytidine deaminase, APOBEC3G (A3G), inhibits replication of human immunodeficiency virus type 1 (HIV-1) by incorporating into virions in the absence of the virally encoded Vif protein (Deltavif virions), at least in part by causing G-to-A hypermutation. To gain insight into the antiretroviral function of A3G, we determined the quantities of A3G molecules that are incorporated in Deltavif virions. We combined three experimental approaches-reversed-phase high-pressure liquid chromatography (HPLC), scintillation proximity assay (SPA), and quantitative immunoblotting-to determine the molar ratio of A3G to HIV-1 capsid protein in Deltavif virions. Our studies revealed that the amount of the A3G incorporated into Deltavif virions was proportional to the level of its expression in the viral producing cells, and the ratio of the A3G to Gag in the Deltavif virions produced from activated human peripheral blood mononuclear cells (PBMC) was approximately 1:439. Based on previous estimates of the stoichiometry of HIV-1 Gag in virions (1400-5000), we conclude that approximately 7 (+/-4) molecules of A3G are incorporated into Deltavif virions produced from human PBMCs. These results indicate that virion incorporation of only a few molecules of A3G is sufficient to inhibit HIV-1 replication. IS - 2 JF - Virology SN - 0042-6822 EP - 256 TI - Stoichiometry of the antiviral protein APOBEC3G in HIV-1 virions. VL - 360 SP - 247 KW - apobec KW - packaging AU - Xu, H AU - Chertova, E AU - Chen, J AU - Ott, DE AU - Roser, JD AU - Hu, WS AU - Pathak, VK PY - 2007/04/10/ UR - http://dx.doi.org/10.1016/j.virol.2006.10.036 ER -